Clinical trial data platform specialist contributing GDPR-compliant health data governance and patient empowerment technology to European research consortia.
MDSOL Europe is the European arm of Medidata Solutions, a major provider of cloud-based technology platforms for clinical trials and life sciences data management. They bring production-grade electronic data capture, clinical data management systems, and regulatory-compliant data infrastructure into academic and public health research consortia. In their H2020 projects they contribute platform expertise and real-world regulatory experience spanning medication adherence tools, patient-facing health information systems, and GDPR-compliant frameworks for reusing clinical trial participant data. Their distinctive value lies in bridging the gap between enterprise clinical research technology and the governance, ethical, and compliance requirements of EU-funded health research.
Both FACILITATE and Gravitate-Health draw on clinical data infrastructure capabilities, with FACILITATE specifically targeting data reutilization frameworks for clinical trial participants.
Gravitate-Health focuses on equipping citizens with health information for active personal health management, including medication adherence and risk minimisation.
FACILITATE is explicitly built around GDPR, ethical and legal frameworks, and transparent data reuse; Gravitate-Health addresses citizen data standards in a regulated eHealth context.
FACILITATE's full title references a transparent and ethical ecosystem for clinical trial data reutilization, placing regulatory compliance at the core of the project design.
Gravitate-Health positions citizens as active health participants by improving the quality and usability of digital health information, with adherence and self-management as key outcomes.
Their first H2020 project (from 2020) centred on the patient-facing side of digital health — self-management, medication adherence, and empowering citizens to engage actively with health information. By 2022, their second project shifted decisively to the back-end infrastructure layer: GDPR compliance, big data, and building ethical-legal frameworks for reusing clinical trial data at scale. This trajectory mirrors a broader industry move from patient engagement applications toward data governance and regulatory compliance infrastructure, suggesting MDSOL Europe is repositioning from a product contributor to a regulatory-compliance and data-platform specialist within health research consortia.
MDSOL Europe is consolidating around the intersection of clinical data infrastructure and EU regulatory compliance — an area that will grow in importance as the European Health Data Space rolls out and demand for GDPR-certified data reuse frameworks increases.
MDSOL Europe joins exclusively as a consortium partner, never as project coordinator, signalling that they contribute specific technology or regulatory expertise rather than drive project strategy or administration. Despite only two projects, they have engaged with 73 distinct partners across 22 countries — numbers that reflect large, multi-stakeholder Horizon health consortia rather than tight bilateral collaborations. This pattern suggests they are valued as a specialist contributor brought into broad alliances for their platform capabilities or compliance credentials, not as a repeat collaborator with a fixed inner circle.
With 73 unique consortium partners across 22 countries from just two projects, MDSOL Europe's network footprint is disproportionately large — a hallmark of Horizon 2020 health pillar consortia that routinely span 20–30 organisations per project. Their geographic reach is genuinely European, with no visible concentration in any single country cluster.
MDSOL Europe stands out in the H2020 health landscape as a non-academic, private-sector technology company that brings enterprise clinical data management infrastructure directly into research consortia — a profile far less common than universities or public research institutes. Their combination of patient-engagement expertise and regulatory compliance depth (GDPR, ethical data reuse, clinical trial frameworks) is a specific and currently high-demand pairing as EU health data policy evolves. For a consortium needing both a credible technology platform and a partner who can navigate the legal-regulatory architecture of clinical data, MDSOL Europe offers a rare dual capability.
